The researchers test an AI software to understand if it should be used for diagnosis of stroke in hospitals.
Early Supported Discharge (ESD) is the discharge of a stroke patient from hospital to their own home. Do these services offer the same benefits to patients as those identified in clinical trials?
Stroke survivors often have very individual hopes for the future, in terms of the goals they would like to achieve. This research will develop and test a Goal setting and Action Planning (G-AP) approach to achieving personal goals through community rehabilitation.
One in five stroke survivors are left with partial or total loss of vision to one side following a stroke. The condition is called hemianopia, and can severely affect a stroke survivor's quality of life.
In stroke survivors, does the clinical effectiveness of 6 months treatment with fluoxetine depend upon its effects on synaptic plasticity in the brain? Can a drug used for depression help stroke recovery by changing connections between brain cells?
Torpor is a natural state of reduced energy use and body temperature. This research will look at the effect of torpor on brain activity and function, and the amount of brain damage caused by ischaemic stroke.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.
Presented at the International Stroke Conference 2016, the final results from the PISTE trial (Pragmatic Ischaemic Stroke Thrombectomy Evaluation) add new evidence for the effectiveness of mechanical clot retrieval (thrombectomy) treatment in the UK.
The aim of this research is to develop and test a simple yet widely-applicable outcome measure for evaluating cognitive rehabilitation after stroke. Consultation with patients and carers will shape the design and content of the measure.
The effect of blood pigments on brain inflammation and survival of nerve cells.